Hambleton Julie 4
4 · IGM Biosciences, Inc. · Filed Jul 29, 2024
Insider Transaction Report
Form 4
Hambleton Julie
Director
Transactions
- Exercise/Conversion
Common Stock
2024-07-25$1.39/sh+15,132$21,033→ 17,132 total - Sale
Common Stock
2024-07-25$14.00/sh−15,132$211,848→ 2,000 total - Exercise/Conversion
Stock Option (right to buy)
2024-07-25−15,132→ 0 totalExercise: $1.39Exp: 2028-12-22→ Common Stock (15,132 underlying)
Footnotes (2)
- [F1]The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2024.
- [F2]All of the shares subject to this option are fully vested and exercisable as of the date hereof.